The unique bioactivities of arsenic-containing secondary
metabolites
have been revealed recently, but studies on arsenic secondary metabolism
in microorganisms have been extremely limited. Here, we focused on
the organoarsenic metabolite with an unknown chemical structure, named
bisenarsan, produced by well-studied model actinomycetes and elucidated
its structure by combining feeding of the putative biosynthetic precursor
(2-hydroxyethyl)arsonic acid to Streptomyces lividans 1326 and detailed NMR analyses. Bisenarsan is the first characterized
actinomycete-derived arsenic secondary metabolite and may function
as a prototoxin form of an antibacterial agent or be a detoxification
product of inorganic arsenic species. We also verified the previously
proposed genes responsible for bisenarsan biosynthesis, especially
the (2-hydroxyethyl)arsonic acid moiety. Notably, we suggest that
a C–As bond in bisenarsan is formed by the intramolecular rearrangement
of a pentavalent arsenic species (arsenoenolpyruvate) by the cofactor-independent
phosphoglycerate mutase homologue BsnN, that is entirely distinct
from the conventional biological C–As bond formation through
As-alkylation of trivalent arsenic species by S-adenosylmethionine-dependent
enzymes. Our findings will speed up the development of arsenic natural
product biosynthesis.